The innate/general resistance system and the adaptive system are the two main subsystems of the immune system. To generate an efficient immune response, the innate and adaptive systems constantly ...

Antibody responses were detected in all vaccine recipients on day 239 (Figure 1A, upper panels). The median binding antibody titer against the WA1/2020 receptor-binding domain was 645 on day 29, 1772 ...

The FDA approved a supplemental biologics license application for Asceniv, expanding its use to younger patients with primary ...

Clinical data from a 16-patient pediatric study demonstrate the safety and efficacy of Asceniv in younger populations, ...

The product is expected to be available in early 2026. The Food and Drug Administration (FDA) has approved Qivigy (immune globulin intravenous [IV], human-kthm) 10% solution for the treatment of ...

Key role of b-cell-based humoral immunity in the clearance of hbv infection For decades, studies have been centralized in anti-HBV cellular immunity, which was thought to have the capacity to control ...

Covid-19 denotes coronavirus disease 2019, CT computed tomography, ICU intensive care unit, MIS-C multisystem inflammatory syndrome in children, ND not determined, PASC postacute sequelae of Covid-19, ...

Qivigy, an IVIG treatment for primary humoral immunodeficiency, received FDA approval, demonstrating safety and efficacy in clinical trials. Kedrion plans significant investments in U.S. plasma ...

One can acquire humoral immunity to a specific infection or disease if administered with antibodies from someone who was previously been exposed to the same infection, circumventing the humoral ...

One can acquire humoral immunity to a specific infection or disease if administered with antibodies from someone who was previously been exposed to the same infection, circumventing the humoral ...